Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aart G Jochemsen

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Cell Cycle (Georgetown, Tex.)|February 24, 2012
Mdmx: a p53 activator?Aart G Jochemsen
Current Opinion in Oncology|November 27, 2013
Reactivation of p53 as therapeutic intervention for malignant melanomaAart G Jochemsen
Cell|February 11, 2010
USP10: friend and foeAart G Jochemsen, Yosef Shiloh
Current Cancer Drug Targets|March 14, 2008
p53: a guide to apoptosisErik Meulmeester, Aart G Jochemsen
Journal of Biomedicine & Biotechnology|May 5, 2011
Functions of MDMX in the modulation of the p53-responseKristiaan Lenos, Aart G Jochemsen
Biochemical and Biophysical Research Communications|May 4, 2005
Mdmx as an essential regulator of p53 activityJean-Christophe Marine, Aart G Jochemsen
Cold Spring Harbor Perspectives in Medicine|July 3, 2016
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and BeyondJean-Christophe Marine, Aart G Jochemsen
Cell Cycle (Georgetown, Tex.)|July 16, 2004
Mdmx and Mdm2: brothers in arms?Jean-Christophe Marine, Aart G Jochemsen
The International Journal of Biochemistry & Cell Biology|December 6, 2001
p63Natalie A Little, Aart G Jochemsen
Cell Cycle (Georgetown, Tex.)|August 6, 2005
ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activationErik Meulmeester, Yaron Pereg, Yosef Shiloh, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Cell Cycle (Georgetown, Tex.)|February 24, 2012
Mdmx: a p53 activator?Aart G Jochemsen
Current Opinion in Oncology|November 27, 2013
Reactivation of p53 as therapeutic intervention for malignant melanomaAart G Jochemsen
Cell|February 11, 2010
USP10: friend and foeAart G Jochemsen, Yosef Shiloh
Current Cancer Drug Targets|March 14, 2008
p53: a guide to apoptosisErik Meulmeester, Aart G Jochemsen
Journal of Biomedicine & Biotechnology|May 5, 2011
Functions of MDMX in the modulation of the p53-responseKristiaan Lenos, Aart G Jochemsen
Biochemical and Biophysical Research Communications|May 4, 2005
Mdmx as an essential regulator of p53 activityJean-Christophe Marine, Aart G Jochemsen
Cold Spring Harbor Perspectives in Medicine|July 3, 2016
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and BeyondJean-Christophe Marine, Aart G Jochemsen
Cell Cycle (Georgetown, Tex.)|July 16, 2004
Mdmx and Mdm2: brothers in arms?Jean-Christophe Marine, Aart G Jochemsen
The International Journal of Biochemistry & Cell Biology|December 6, 2001
p63Natalie A Little, Aart G Jochemsen
Cell Cycle (Georgetown, Tex.)|August 6, 2005
ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activationErik Meulmeester, Yaron Pereg, Yosef Shiloh, et al.
Pageof 7